| 31. |
-
Building and Re-building Sustainable Communities : Reports from the Superbs project
- 2003. - 1
-
Samlingsverk (redaktörskap) (populärvet., debatt m.m.)abstract
- CONTENTS1. How do people want to live? Dorota Wlodarczyk and Malgorzata Dymnicka2. Garden city urban patterns Dorota Wlodarczyk3. Building a sustainable neighbourhood – Kronsberg Madeleine Granvik, Dorota Wlodarczyk and Lars Rydén4. Urban planning and land-use in post-socialist Estonia Jussi Jauhiainen5. Development of an old wooden house residential district Jussi Jauhiainen6. Development of a former military district Jussi Jauhiainen7. Development of an industrial district Jussi Jauhiainen8. Protecting the past of historical Veliky Novgorod Igor Alexandrov, Ludmila Petrova, Vladimir Druzhinin and Tatyana Kaucia9. Urban planning in post-soviet Novgorod Igor Bezlakovsky, Vladimir Kuzmichev and Tatyana Ivchenko10. Decision support techniques in urban planning Saulius Lukosius and Linas Kliucininkas
|
|
| 32. |
- Carlsson, Sven G., 1935, et al.
(författare)
-
Vad är klinisk psykologi?
- 2005
-
Ingår i: Psykologtidningen. - 0280-9702. ; :13, s. 8-10
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
| 33. |
|
|
| 34. |
- Dotevall, Annika, 1957, et al.
(författare)
-
Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease
- 2007
-
Ingår i: European Heart Journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 28:3, s. 310-315
-
Tidskriftsartikel (refereegranskat)abstract
- Aim To investigate the prevalence of diabetes and impaired glucose regulation (IGR) in a large cohort of men and women with coronary artery disease (CAD), and to describe the effect of abnormal glucose regulation by sex on symptoms, clinical course, and diagnosis. Methods and results A total of 4855 patients with CAD (median age 66 years; 29% women) were analysed within the framework of the Euro Heart Survey on Diabetes and the Heart. In all, 967 (28.1%) men and 528 (37.5%) women had diabetes. Of 3185 patients with unknown glucose regulation, 1835 (57.6%; 1400 men and 435 women) underwent an oral glucose tolerance test revealing that 17% of the men and 18% of the women had diabetes and 35 and 39% impaired glucose tolerance or impaired fasting glucose, respectively. Thus, only 19% of the women and 27% of the men had a normal glucose regulation. Women were more likely to have diabetes than men with an odds ratio (OR) of 1.32 (1.13–1.54). The corresponding OR for abnormal glucose regulation was 1.34 (1.11–1.62). Gender did not influence differences in clinical presentation between patients with diabetes or IGR and those with a normal glucose metabolism. Conclusion Abnormal glucose regulation was more common in women than men with CAD. However, the influence of diabetes on presenting symptoms and clinical course was similar in men and women.
|
|
| 35. |
- Eckerberg, Katarina, et al.
(författare)
-
Varför brister politikerna när det gäller miljömålen?
- 2012
-
Ingår i: Dagens Nyheter. - 1101-2447.
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Vad ska vi svara? Politikernas ambitiösa miljömål uppfylls sällan eller aldrig. När våra elever frågar oss varför blir vi ofta svaret skyldiga. Om politikerna inte vill att väljarna ska dra slutsatsen att de har misslyckats, måste de ange en realistisk väg att nå de uppsatta målen. Det skulle väcka respekt, skriver ledande forskare och samhällsplanerare.
|
|
| 36. |
|
|
| 37. |
- Edelstam, Gunilla, et al.
(författare)
-
23. The rule of law
- 2002. - 1
-
Ingår i: The Baltic Sea Region. - Uppsala : Baltic University Press. - 9197357987 ; , s. 308-321
-
Bokkapitel (populärvet., debatt m.m.)
|
|
| 38. |
- Engström, Carl-Peter, 1945, et al.
(författare)
-
Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study.
- 1996
-
Ingår i: Thorax. - 0040-6376. ; 51:8, s. 825-30
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Self-assessment questionnaires which measure the functional and affective consequences of chronic obstructive pulmonary disease (COPD) give valuable information about the effects of the disease and may serve as important tools with which to evaluate treatment. METHODS: A cross sectional comparative study was performed between patients with COPD (n = 68), stratified according to pulmonary function, and a healthy control group (n = 89). A battery of well established clinical and quality of life measures (the Sickness Impact Profile (SIP), Mood Adjective Check List (MACL), and Hospital Anxiety and Depression scale (HAD)) was used to examine in which functional and affective aspects the patient group differed from the control group and how these measures related to pulmonary function and smoking habits. RESULTS: Compared with the controls, COPD affected functional status in most areas, not just those requiring physical activity. Forty six patients with forced expiratory volume in one second (FEV1) below 50% predicted showed particularly high levels of dysfunction in ambulation, eating, home management, and recreation/ pastimes (SIP). Despite this, their level of psychosocial functioning and mood status was little different from that of the healthy controls. Among the patients, a subgroup reported substantial psychological distress, but mood status was only weakly, or not at all, related to pulmonary function. Smoking habits did not affect functional status or well being. CONCLUSIONS: Quality of life is not significantly affected in patients with mild to moderate loss of pulmonary function, possibly due to coping and/or pulmonary reserve capacity. This suggests that generic self-assessment questionnaires are of limited value for detecting the early consequences of COPD. However, in later stages of the disease they are sensitive enough to discriminate between patients with different levels of pulmonary dysfunction. The low correlations between the indices of pulmonary function and the indices of affective status suggest that well being depends, to a large extent, on factors outside the clinical domain.
|
|
| 39. |
-
Environmental Science : Understanding, protecting and managing the environment in the Baltic Sea Region
- 2003. - 1
-
Samlingsverk (redaktörskap) (populärvet., debatt m.m.)abstract
- CONTENTSPart A Understanding the EnvironmentChapter 1. Discovering the Environmental DilemmaChapter 2. How the Environment Works - Turnover of Matter and EnergyChapter 3. Ecology and EcosystemsChapter 4. The Baltic Sea Basin - Nature, History, and EconomyChapter 5. The Baltic SeaChapter 6. Life in the Baltic SeaPart B Environmental ImpactsChapter 7. Society and Landscape - Space Intrusion and Habitat DestructionChapter 8. Changing the Living World - Shrinking BiodiversityChapter 9. A New Regime for Nutrient Turnover - EutrophicationChapter 10. Impacts on the Global Atmosphere - Climate Change and Ozone DepletionChapter 11. Air Pollution - Acid Rain and Radioactive FalloutChapter 12. Metal Flows and Environmental ImpactChapter 13. Industrial Society and Chemical PollutionChapter 14. How Pollutants Affect Life - Toxicology and Human HealthChapter 15. The Damaged Environment - Distribution, Interaction, and Longevity of Environmental ImpactPart C Society and EnvironmentChapter 16. Environmental Engineering and the Technology of Clean AirChapter 17. Resource Management and the Technology of Clean WaterChapter 18. Soil Protection and Solid Waste ManagementChapter 19. The Cost of Pollution - Environmental EconomicsChapter 20. Legal Protection of the EnvironmentChapter 21. Behaviour and the Environment - Ethics, Education, and LifestyleChapter 22. Making and Implementing Environmental PolicyChapter 23. International Co-operation for the EnvironmentPart D Managing the EnvironmentChapter 24. Environmental ManagementChapter 25. The Prospect of Sustainable Development
|
|
| 40. |
- Ferrannini, Giulia, et al.
(författare)
-
Antiphospholipid antibodies in patients with dysglycaemia : A neglected cardiovascular risk factor?
- 2020
-
Ingår i: Diabetes & Vascular Disease Research. - : SAGE PUBLICATIONS LTD. - 1479-1641 .- 1752-8984. ; 17:3
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Cardiovascular disease is a serious complication in patients with dysglycaemia, defined as either type 2 diabetes or impaired glucose tolerance. Research focusing on the identification of potential markers for atherothrombotic disease in these subjects is warranted. The antiphospholipid syndrome is a common acquired prothrombotic condition, defined by a combination of thrombotic events and/or obstetric morbidity and positivity of specific antiphospholipid antibodies. Available information on antiphospholipid antibodies in dysglycaemia is scarce. Objective: This study investigates the association between antiphospholipid antibodies and dysglycaemia. Patients/Methods: The PAROKRANK (periodontitis and its relation to coronary artery disease) study included 805 patients, investigated 6-10 weeks after a first myocardial infarction, and 805 matched controls. Participants without known diabetes (91%) underwent an oral glucose tolerance test. Associations between antiphospholipid antibodies (anti-cardiolipin and anti-beta 2 glycoprotein-I IgG, IgM and IgA) and dysglycaemia were analysed. Results: In total, 137 (9%) subjects had previously known type 2 diabetes and 371 (23%) newly diagnosed dysglycaemia. Compared with the normoglycaemic participants, those with dysglycaemia had a higher proportion with first myocardial infarction (61% vs 45%,p < 0.0001) and were more often antiphospholipid antibody IgG positive (8% vs 5%;p = 0.013). HbA1c, fasting glucose and 2-h glucose were significantly associated to antiphospholipid antibody IgG. Odds ratios (ORs) were 1.04 (95% confidence interval [CI] 1.02-1.06), 1.14 (95% CI 1.00 - 1.27) and 1.12 (95% CI 1.04 - 1.21), respectively, after adjustments for age, gender and smoking. Conclusions: This study reports an association between antiphospholipid antibody IgG positivity and dysglycaemia. Further studies are needed to verify these findings and to investigate if antithrombotic therapy reduces vascular complications in antiphospholipid antibody positive subjects with dysglycaemia.
|
|
